Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT02014558 · COMPLETED
Trial details
- NCT number
- NCT02014558
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-09
- Primary completion
- 2017-08-04
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.